InvestorsHub Logo
Followers 37
Posts 2733
Boards Moderated 0
Alias Born 04/22/2019

Re: None

Friday, 02/23/2024 1:23:34 PM

Friday, February 23, 2024 1:23:34 PM

Post# of 64228
$TSOI investors diving into series B preferred shares aren't just blindly jumping into Series B funding—they're fully aware that JADICELLS are far superior than Sabizabulin from $VERU, Ruxolitinib from $INCY, Extracellular Vesicle from Direct Biologics, LLC, and EB05 from $EDSA— It's like comparing a sleek sports car to a rusty old bicycle—there's just no competition! So, buckle up, investors, because we're about to take this ARDS treatment race to warp speed with JADICELLS leading the charge!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News